ROSSARI BIOTECH Financial Statement Analysis
|
||
|
The Revenues of ROSSARI BIOTECH have increased by 109.06% YoY .
The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 9.64 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ROSSARI BIOTECH Last 5 Annual Financial Results
[BOM: 543213|NSE : ROSSARI]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹1,483 Cr | ₹709 Cr | ₹600 Cr | ₹516 Cr | ₹291,798,727 Cr |
| Expenses | ₹1,307 Cr | ₹586 Cr | ₹495 Cr | ₹439 Cr | ₹247,141,846 Cr |
| Operating Profit (Excl OI) | ₹176 Cr | ₹123 Cr | ₹105 Cr | ₹78 Cr | ₹44,656,881 Cr |
| Other Income | ₹19 Cr | ₹9.19 Cr | ₹3.72 Cr | ₹0.91 Cr | ₹1,407,285 Cr |
| Interest | ₹13 Cr | ₹2.99 Cr | ₹3.56 Cr | ₹2.88 Cr | ₹1,356,536 Cr |
| Depreciation | ₹48 Cr | ₹23 Cr | ₹17 Cr | ₹12 Cr | ₹5,160,846 Cr |
| Profit Before Tax | ₹136 Cr | ₹107 Cr | ₹88 Cr | ₹63 Cr | ₹39,546,784 Cr |
| Profit After Tax | ₹98 Cr | ₹80 Cr | ₹65 Cr | ₹46 Cr | ₹29,013,037 Cr |
| Consolidated Net Profit | ₹98 Cr | ₹80 Cr | ₹65 Cr | ₹46 Cr | ₹29,013,037 Cr |
| Earnings Per Share (Rs) | ₹19.45 | ₹17.74 | ₹15.45 | ₹12.86 | ₹103.83 |
| PAT Margin (%) | 6.43 | 6.56 | 11.19 | 10.82 | 8.84 |
| ROE(%) | 12.52 | 16.17 | 23.11 | 31.83 | 41.88 |
| ROCE(%) | 18.48 | 24.37 | 28.81 | 37.93 | 54.40 |
| Total Debt/Equity(x) | 0.08 | 0.01 | 0.00 | 0.23 | 0.04 |
Key Financials |
||
| Market Cap | : | ₹ 4,194.1 Cr |
| Revenue (TTM) | : | ₹ 1,764.3 Cr |
| Net Profit(TTM) | : | ₹ 125.3 Cr |
| EPS (TTM) | : | ₹ 22.7 |
| P/E (TTM) | : | 33.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ROSSARI BIOTECH | -2.7% | -12.2% | 14.9% |
| PIDILITE INDUSTRIES | 4% | 9.7% | 25.7% |
| SOLAR INDUSTRIES INDIA | 7.9% | 35.1% | 139.9% |
| SRF | 6.1% | 8.2% | 8.6% |
| GUJARAT FLUOROCHEMICALS | -0.8% | -13% | 0.9% |
| DEEPAK NITRITE | 1.2% | -7.2% | 20.3% |
| TATA CHEMICALS | -3.1% | 11.2% | 9.8% |
| GODREJ INDUSTRIES | 2.6% | -5.7% | 83.1% |
| AARTI INDUSTRIES | 3.2% | -2.6% | 25.8% |
ROSSARI BIOTECH Revenues
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | 109.06 % |
| 5 Yr CAGR | -95.25 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹1,483 Cr | 109.06 | |
| Mar2022 | ₹709 Cr | 18.21 | |
| Mar2021 | ₹600 Cr | 16.25 | |
| Mar2020 | ₹516 Cr | -100.00 | |
| Mar2019 | ₹291,798,727 Cr | - | |
ROSSARI BIOTECH Operating Profit
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | 43.26 % |
| 5 Yr CAGR | -95.54 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹176 Cr | 43.26 | |
| Mar2022 | ₹123 Cr | 17.48 | |
| Mar2021 | ₹105 Cr | 35.06 | |
| Mar2020 | ₹78 Cr | -100.00 | |
| Mar2019 | ₹44,656,881 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -31.47 % |
| 5 Yr CAGR | -6.11 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 11.89% | -31.47 | |
| Mar2022 | 17.35% | -0.57 | |
| Mar2021 | 17.45% | 16.18 | |
| Mar2020 | 15.02% | -1.83 | |
| Mar2019 | 15.3% | - | |
ROSSARI BIOTECH Profit After Tax
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | 21.76 % |
| 5 Yr CAGR | -95.72 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹98 Cr | 21.76 | |
| Mar2022 | ₹80 Cr | 22.94 | |
| Mar2021 | ₹65 Cr | 42.84 | |
| Mar2020 | ₹46 Cr | -100.00 | |
| Mar2019 | ₹29,013,037 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -1.98 % |
| 5 Yr CAGR | -7.65 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 6.43 % | -1.98 | |
| Mar2022 | 6.56 % | -41.38 | |
| Mar2021 | 11.19 % | 3.42 | |
| Mar2020 | 10.82 % | 22.40 | |
| Mar2019 | 8.84 % | - | |
ROSSARI BIOTECH Earnings Per Share (EPS)
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | 9.64 % |
| 5 Yr CAGR | -34.21 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹19 | 9.64 | |
| Mar2022 | ₹18 | 14.82 | |
| Mar2021 | ₹15 | 20.14 | |
| Mar2020 | ₹13 | -87.61 | |
| Mar2019 | ₹104 | - | |
ROSSARI BIOTECH Return on Capital Employed (ROCE)
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | -24.17 % |
| 5 Yr CAGR | -23.66 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 18.48% | -24.17 | |
| Mar2022 | 24.37% | -15.41 | |
| Mar2021 | 28.81% | -24.04 | |
| Mar2020 | 37.93% | -30.28 | |
| Mar2019 | 54.4% | - | |
ROSSARI BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹759.8 |
| Current MarketCap | : | ₹ 4,194.1 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ROSSARI BIOTECH | -2.7% |
-12.2% |
14.9% |
| SENSEX | 1.3% |
2.6% |
24% |
ROSSARI BIOTECH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE BASIC MATERIALS | 3.1% | 10.9% | 37.6% |
| S&P BSE 250 SMALLCAP | 2.5% | 12.8% | 64.9% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE 400 MIDSMALLCAP | 1.9% | 9.9% | 59.4% |
No NSE index found
You may also like the below Video Courses
FAQ about ROSSARI BIOTECH Financials
How the annual revenues of ROSSARI BIOTECH have changed ?
The Revenues of ROSSARI BIOTECH have increased by 109.06% YoY .
How the Earnings per Share (EPS) of ROSSARI BIOTECH have changed?
The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 9.64 % YoY .
Check out Intrinsic Value of Peers of ROSSARI BIOTECH
Compare Stock Analytics of Peers of ROSSARI BIOTECH
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs
